484 related articles for article (PubMed ID: 27480145)
21. Randomized phase II study of neoadjuvant combined-modality chemoradiation for distal rectal cancer: Radiation Therapy Oncology Group Trial 0012.
Mohiuddin M; Winter K; Mitchell E; Hanna N; Yuen A; Nichols C; Shane R; Hayostek C; Willett C;
J Clin Oncol; 2006 Feb; 24(4):650-5. PubMed ID: 16446336
[TBL] [Abstract][Full Text] [Related]
22. Adjuvant vs. neoadjuvant radiochemotherapy for locally advanced rectal cancer: the German trial CAO/ARO/AIO-94.
Sauer R; Fietkau R; Wittekind C; Rödel C; Martus P; Hohenberger W; Tschmelitsch J; Sabitzer H; Karstens JH; Becker H; Hess C; Raab R;
Colorectal Dis; 2003 Sep; 5(5):406-15. PubMed ID: 12925071
[TBL] [Abstract][Full Text] [Related]
23. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.
Valentini V; Morganti AG; Gambacorta MA; Mohiuddin M; Doglietto GB; Coco C; De Paoli A; Rossi C; Di Russo A; Valvo F; Bolzicco G; Dalla Palma M;
Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1129-39. PubMed ID: 16414206
[TBL] [Abstract][Full Text] [Related]
24. Preliminary analysis of a randomized clinical trial of adjuvant postoperative RT vs. postoperative RT plus 5-FU and levamisole in patients with TNM stage II-III resectable rectal cancer.
Cafiero F; Gipponi M; Peressini A; Bertoglio S; Lionetto R
J Surg Oncol; 2000 Oct; 75(2):80-8. PubMed ID: 11064385
[TBL] [Abstract][Full Text] [Related]
25. Preoperative Treatment of Locally Advanced Rectal Cancer.
Schrag D; Shi Q; Weiser MR; Gollub MJ; Saltz LB; Musher BL; Goldberg J; Al Baghdadi T; Goodman KA; McWilliams RR; Farma JM; George TJ; Kennecke HF; Shergill A; Montemurro M; Nelson GD; Colgrove B; Gordon V; Venook AP; O'Reilly EM; Meyerhardt JA; Dueck AC; Basch E; Chang GJ; Mamon HJ
N Engl J Med; 2023 Jul; 389(4):322-334. PubMed ID: 37272534
[TBL] [Abstract][Full Text] [Related]
26. Improved incidence of pT0 downstaged surgical specimens in locally advanced rectal cancer (LARC) treated with induction oxaliplatin plus 5-fluorouracil and preoperative chemoradiation.
Calvo FA; Serrano FJ; Diaz-González JA; Gomez-Espi M; Lozano E; Garcia R; de la Mata D; Arranz JA; García-Alfonso P; Pérez-Manga G; Alvarez E
Ann Oncol; 2006 Jul; 17(7):1103-10. PubMed ID: 16670204
[TBL] [Abstract][Full Text] [Related]
27. A clinical trial to evaluate the worth of preoperative multimodality therapy in patients with operable carcinoma of the rectum: a progress report of National Surgical Breast and Bowel Project Protocol R-03.
Hyams DM; Mamounas EP; Petrelli N; Rockette H; Jones J; Wieand HS; Deutsch M; Wickerham L; Fisher B; Wolmark N
Dis Colon Rectum; 1997 Feb; 40(2):131-9. PubMed ID: 9075745
[TBL] [Abstract][Full Text] [Related]
28. Postoperative radiochemotherapy in rectal cancer comparison of two combination schemes: alternating versus concomitant.
Valencia J; Escó R; Polo S; Bascón N; Escudero P; Alonso V
Tumori; 2004; 90(2):216-24. PubMed ID: 15237585
[TBL] [Abstract][Full Text] [Related]
29. Prognostic implications of response to preoperative infusional chemoradiation in locally advanced rectal cancer.
Janjan NA; Abbruzzese J; Pazdur R; Khoo VS; Cleary K; Dubrow R; Ajani J; Rich TA; Goswitz MS; Evetts PA; Allen PK; Lynch PM; Skibber JM
Radiother Oncol; 1999 May; 51(2):153-60. PubMed ID: 10435807
[TBL] [Abstract][Full Text] [Related]
30. Alliance for clinical trials in oncology (ALLIANCE) trial A021501: preoperative extended chemotherapy vs. chemotherapy plus hypofractionated radiation therapy for borderline resectable adenocarcinoma of the head of the pancreas.
Katz MHG; Ou FS; Herman JM; Ahmad SA; Wolpin B; Marsh R; Behr S; Shi Q; Chuong M; Schwartz LH; Frankel W; Collisson E; Koay EJ; Hubbard JM; Leenstra JL; Meyerhardt J; O'Reilly E;
BMC Cancer; 2017 Jul; 17(1):505. PubMed ID: 28750659
[TBL] [Abstract][Full Text] [Related]
31. Challenges and solutions in the design and execution of the PROSPECT Phase II/III neoadjuvant rectal cancer trial (NCCTG N1048/Alliance).
Schrag D; Weiser M; Saltz L; Mamon H; Gollub M; Basch E; Venook A; Shi Q
Clin Trials; 2019 Apr; 16(2):165-175. PubMed ID: 30688523
[TBL] [Abstract][Full Text] [Related]
32. Initial safety report of NSABP C-08: A randomized phase III study of modified FOLFOX6 with or without bevacizumab for the adjuvant treatment of patients with stage II or III colon cancer.
Allegra CJ; Yothers G; O'Connell MJ; Sharif S; Colangelo LH; Lopa SH; Petrelli NJ; Goldberg RM; Atkins JN; Seay TE; Fehrenbacher L; O'Reilly S; Chu L; Azar CA; Wolmark N
J Clin Oncol; 2009 Jul; 27(20):3385-90. PubMed ID: 19414665
[TBL] [Abstract][Full Text] [Related]
33. Preoperative chemotherapy and pelvic radiation for tethered or fixed rectal cancer: a phase II dose escalation study.
Chan AK; Wong AO; Langevin J; Jenken D; Heine J; Buie D; Johnson DR
Int J Radiat Oncol Biol Phys; 2000 Oct; 48(3):843-56. PubMed ID: 11020583
[TBL] [Abstract][Full Text] [Related]
34. Chemotherapy with preoperative radiotherapy in rectal cancer.
Bosset JF; Collette L; Calais G; Mineur L; Maingon P; Radosevic-Jelic L; Daban A; Bardet E; Beny A; Ollier JC;
N Engl J Med; 2006 Sep; 355(11):1114-23. PubMed ID: 16971718
[TBL] [Abstract][Full Text] [Related]
35. Oxaliplatin combined with infusional 5-fluorouracil and concomitant radiotherapy in inoperable and metastatic rectal cancer: a phase I trial.
Loi S; Ngan SY; Hicks RJ; Mukesh B; Mitchell P; Michael M; Zalcberg J; Leong T; Lim-Joon D; Mackay J; Rischin D
Br J Cancer; 2005 Feb; 92(4):655-61. PubMed ID: 15700033
[TBL] [Abstract][Full Text] [Related]
36. Five fractions of preoperative radiotherapy for selected cases of rectal carcinoma: long-term tumor control and tolerance to treatment.
Myerson RJ; Genovesi D; Lockett MA; Birnbaum E; Fleshman J; Fry R; Kodner I; Menteer J; Picus J; Read T; Walz B
Int J Radiat Oncol Biol Phys; 1999 Feb; 43(3):537-43. PubMed ID: 10078634
[TBL] [Abstract][Full Text] [Related]
37. Identification of a biomarker profile associated with resistance to neoadjuvant chemoradiation therapy in rectal cancer.
Garcia-Aguilar J; Chen Z; Smith DD; Li W; Madoff RD; Cataldo P; Marcet J; Pastor C
Ann Surg; 2011 Sep; 254(3):486-92; discussion 492-3. PubMed ID: 21865946
[TBL] [Abstract][Full Text] [Related]
38. Rationale and Design of the IROCAS Study: Multicenter, International, Randomized Phase 3 Trial Comparing Adjuvant Modified (m) FOLFIRINOX to mFOLFOX6 in Patients With High-Risk Stage III (pT4 and/or N2) Colon Cancer-A UNICANCER GI-PRODIGE Trial.
Bennouna J; André T; Campion L; Hiret S; Miglianico L; Mineur L; Touchefeu Y; Artru P; Asmis T; Bouché O; Borde F; Kavan P; Lam YH; Rajpar LS; Emile JF; Jouffroy C; Gill S; Taïeb J
Clin Colorectal Cancer; 2019 Mar; 18(1):e69-e73. PubMed ID: 30415988
[TBL] [Abstract][Full Text] [Related]
39. Safety and efficacy of preoperative mFOLFOX6 regimen chemotherapy for locally resectable advanced rectal cancer.
Liu L; Jiang Z
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2021 Jan; 46(1):32-38. PubMed ID: 33678634
[TBL] [Abstract][Full Text] [Related]
40. Fluorouracil and high-dose leucovorin with radiotherapy as adjuvant therapy for rectal cancer. Results of a phase II study.
Giralt J; Rubio D; Maldonado X; Naval J; Casado S; Lara F; Roselló JM; Armengol M
Acta Oncol; 1997; 36(1):51-4. PubMed ID: 9090966
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]